Thank you, likewise I’ve not found a lot of recent documents apart from patents and the translated City of Hope article about Professor Chen & team looking into role of FTO in cancer and discovering that Bisantrene was best in class among 260,000 drugs with lower risks, from 2020. It didn’t mention Race Oncology though, just the research so was aimed at professionals, not investors.
This was the research that led to pivot to 3 pillar strategy once FTO became front and centre.
If I start finding more documents in Japanese it might be a good sign that the word is out and we’ve been pipped on the radar.
Understanding RAC, page-41
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.80 |
Change
0.045(2.57%) |
Mkt cap ! $302.3M | |||
| Open | High | Low | Value | Volume |
| $1.82 | $1.82 | $1.78 | $39.09K | 21.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5617 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.80 | 3199 | 3 |
View Market Depth
| Last trade - 11.47am 10/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |